Posters presented at the 2025 American Academy of Dermatology Annual Meeting found bimekizumab to have benefits beyond safety ...

Almirall has announced that it will be hosting the 16th edition of its Skin Academy, a conference that encourages ...

Almirall, a global pharmaceutical company dedicated to medical dermatology hosts the 16th edition of Skin Academy, a premier conference for healthcare professionals in the field of dermatology. This ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where the ...

However, for the Company, 2024 was both a “year of restructuring” amidst challenges and a “year of breakthroughs” with emerging potentials. Although the overall performance is experiencing short-term ...

Chronic stress is a silent killer that many Nigerians endure or ignore without adequate regard for its dangers. While ...

Johnson & Johnson JNJ announced that the FDA has granted approval to its key drug, Tremfya, for its second inflammatory bowel disease (IBD) condition — moderately to severely active Crohn’s disease ...

Time is a scarce resource at the doctor’s office, with the average visit lasting nearly 19 minutes, according to 2023 research published in Journal of the American Medical Association Health Forum.